Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Kumar Sah

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 7, 2025
Advances in auricular drug delivery for the management of different otitic conditionsNiloy Barman, Sunil Kumar Sah, Subhadeep Roy, et al.
Molecular Pharmaceutics|July 17, 2023
Bootstrap Statistics and Its Application in Disintegration and Dissolution Data AnalysisSantanu Kaity, Sunil Kumar Sah, Tukaram Karanwad, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 26, 2022
Green Synthesized Nanoparticles as a Plausible Therapeutic Strategy Against Hepatocellular Carcinoma: An Update on its Preclinical and Clinical RelevanceGopika Chandrababu, Sunil Kumar Sah, Ayana R Kumar, et al.
Drug Discovery Today|May 5, 2024
Premix technologies for drug delivery: manufacturing, applications, and opportunities in regulatory filingMakka Krupali Ashokbhai, Lohare Rahul Sanjay, Sunil Kumar Sah, et al.
Biofabrication|March 25, 2025
Fabrication of multilayer heterogeneous cell assembly for pathophysiologically relevant 3D<i>in-vitro</i>IBD disease model for high throughput drug screeningMamta Kumari, Kamare Alam, Santanu Kaity, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 30, 2026
Mesalamine premix-based delayed release formulation and its efficacy assessment using a 3D in-vitro gut model for inflammatory bowel diseaseSunil Kumar Sah, Mamta Kumari, Lohare Rahul Sanjay, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 2, 2024
A 3D in-vitro biomimicking Caco-2 intestinal permeability model-based assessment of physically modified telmisartan towards an alkalizer-free formulation developmentSunil Kumar Sah, Kamare Alam, Mamta Kumari, et al.
Vaccines|May 28, 2022
Factors Influencing COVID-19 Vaccine Uptake among Nepali People in the UK: A Qualitative StudyPadam Simkhada, Pasang Tamang, Laxmi Timilsina, et al.
Nanoscale|October 7, 2024
Rebamipide nanocrystal with improved physicomechanical properties and its assessment through bio-mimicking 3D intestinal permeability modelMd Samim Sardar, Kardile Punam Kashinath, Mamta Kumari, et al.
International Journal of Pharmaceutics|September 8, 2024
Manifesting the Dasatinib-gallic acid co-amorphous system to augment anticancer potential: Physicochemical characterization, in silico molecular simulation, ex vivo permeability, and in vitro efficacyTanmoy Kanp, Anish Dhuri, Mayur Aalhate, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 7, 2025
Advances in auricular drug delivery for the management of different otitic conditionsNiloy Barman, Sunil Kumar Sah, Subhadeep Roy, et al.
Molecular Pharmaceutics|July 17, 2023
Bootstrap Statistics and Its Application in Disintegration and Dissolution Data AnalysisSantanu Kaity, Sunil Kumar Sah, Tukaram Karanwad, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 26, 2022
Green Synthesized Nanoparticles as a Plausible Therapeutic Strategy Against Hepatocellular Carcinoma: An Update on its Preclinical and Clinical RelevanceGopika Chandrababu, Sunil Kumar Sah, Ayana R Kumar, et al.
Drug Discovery Today|May 5, 2024
Premix technologies for drug delivery: manufacturing, applications, and opportunities in regulatory filingMakka Krupali Ashokbhai, Lohare Rahul Sanjay, Sunil Kumar Sah, et al.
Biofabrication|March 25, 2025
Fabrication of multilayer heterogeneous cell assembly for pathophysiologically relevant 3D<i>in-vitro</i>IBD disease model for high throughput drug screeningMamta Kumari, Kamare Alam, Santanu Kaity, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 30, 2026
Mesalamine premix-based delayed release formulation and its efficacy assessment using a 3D in-vitro gut model for inflammatory bowel diseaseSunil Kumar Sah, Mamta Kumari, Lohare Rahul Sanjay, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 2, 2024
A 3D in-vitro biomimicking Caco-2 intestinal permeability model-based assessment of physically modified telmisartan towards an alkalizer-free formulation developmentSunil Kumar Sah, Kamare Alam, Mamta Kumari, et al.
Vaccines|May 28, 2022
Factors Influencing COVID-19 Vaccine Uptake among Nepali People in the UK: A Qualitative StudyPadam Simkhada, Pasang Tamang, Laxmi Timilsina, et al.
Nanoscale|October 7, 2024
Rebamipide nanocrystal with improved physicomechanical properties and its assessment through bio-mimicking 3D intestinal permeability modelMd Samim Sardar, Kardile Punam Kashinath, Mamta Kumari, et al.
International Journal of Pharmaceutics|September 8, 2024
Manifesting the Dasatinib-gallic acid co-amorphous system to augment anticancer potential: Physicochemical characterization, in silico molecular simulation, ex vivo permeability, and in vitro efficacyTanmoy Kanp, Anish Dhuri, Mayur Aalhate, et al.
Pageof 2